BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30176824)

  • 1. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
    Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
    BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
    Shim SR; Kim SJ; Kim SI; Cho DS
    World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
    Pu Z; Wang Q; Xie H; Wang G; Hao H
    Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
    PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
    Kim SI; Kim SJ; Kim SJ; Cho DS
    Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.
    Hu K; Lou L; Ye J; Zhang S
    BMJ Open; 2015 Apr; 5(4):e006404. PubMed ID: 25854964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
    Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y
    Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis.
    Xu Y; Qi Y; Zhang J; Lu Y; Song J; Dong B; Kong W; Xue W; Huang Y
    Tumour Biol; 2014 Jul; 35(7):6633-40. PubMed ID: 24699995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
    Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
    Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
    Du Y; Long Q; Guan B; Mu L
    Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
    Wang X; Su S; Guo Y
    Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
    Xiong C; Liu H; Chen Z; Yu Y; Liang C
    Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies.
    Chen L; Li H; Gu L; Ma X; Li X; Gao Y; Zhang Y; Shen D; Fan Y; Wang B; Bao X; Zhang X
    Medicine (Baltimore); 2015 Jul; 94(26):e1055. PubMed ID: 26131819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
    Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.